Back
Kymera Therapeutics Vs. Ally Financial Industry Stock Comparison
Buy
62
KYMR
Kymera Therapeutics
Last Price:
48.11
Seasonality Move:
25.63%
Sell
24
ALLY
Ally Financial
Last Price:
33.89
Seasonality Move:
0.2%
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $48.48. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Ally Financial (ALLY)
is a Sell
Is Ally Financial a Buy, Sell or Hold?
- The current Ally Financial [ALLY] share price is $33.03. The Score for ALLY is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- ALLY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $48.48
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALLY Stock Price Chart
What is Ally Financial's stock price today?
-
The Ally Financial share price today is $33.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLY is experiencing slight selling pressure.
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 59.28 | Buy |
| Chaikin Money Flow: | 246739 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.14 - 48.22) | Buy |
| Bollinger Bands (100): | (33.06 - 45.04) | Buy |
ALLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.26 | Sell |
| Relative Strength Index (14 RSI): | 22.43 | Sell |
| Chaikin Money Flow: | -154407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.31 - 43.69) | Sell |
| Bollinger Bands (100): | (37.83 - 42.61) | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.14 | Buy |
| 20-day SMA: | 46.93 | Buy |
| 50-day SMA: | 44.24 | Buy |
| 200-day SMA: | 36.1 | Buy |
| 8-day EMA: | 46.5 | Buy |
| 20-day EMA: | 46.08 | Buy |
| 50-day EMA: | 43.68 | Buy |
| 200-day EMA: | 36.51 | Buy |
ALLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.57 | Sell |
| 20-day SMA: | 39.7 | Sell |
| 50-day SMA: | 41.09 | Sell |
| 200-day SMA: | 38.07 | Sell |
| 8-day EMA: | 35.23 | Sell |
| 20-day EMA: | 38.16 | Sell |
| 50-day EMA: | 39.85 | Sell |
| 200-day EMA: | 37.68 | Sell |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.
Ally Financial Earnings Growth & ALLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.75 per share, a decrease this year of $0.01 per share, and an increase next year of $2.36 per share.
Kymera Therapeutics Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ally Financial Technical Analysis
| Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||